Livingstone Health Holdings Management

Management Kriterienprüfungen 2/4

Livingstone Health Holdings CEO ist Wilson Tay , ernannt in Jan 2021, hat eine Amtszeit von 3.83 Jahren. besitzt direkt 7.9% der Aktien des Unternehmens, im Wert von SGD1.02M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.8 Jahre bzw. 5 Jahre.

Wichtige Informationen

Wilson Tay

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	3.8yrs
Eigentum des Geschäftsführers	7.9%
Durchschnittliche Amtszeit des Managements	3.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	5yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Wilson Tay (45 yo)

3.8yrs

Amtszeit

Dr. Ching Yit Tay is also known as Wilson, M.B.B.S. (Singapore), M.Med Anaes (Singapore), F.A.M.S. (Anaes), F.I.P.P. (WIP, USA), C.I.P.S. (WIP, USA) serves as Chief Executive Officer at Livingstone Health...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Ching Yit Tay	Executive Director & CEO	3.8yrs	keine Daten	7.9% SGD 1.0m
Qingyuan Wong	Chief Financial Officer	less than a year	keine Daten	0.74% SGD 95.8k
Yung Sern Ng	Chief Commercial Officer & Executive Director	4.8yrs	keine Daten	1.71% SGD 220.5k
Chua Hshan Cher	Deputy CEO & Head of Family Medicine	no data	keine Daten	0.65% SGD 84.3k
Jong Yuh Gn	Secretary	no data	keine Daten	keine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: PRHDas Führungsteam des Unternehmens gilt als erfahren (3.8 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Ching Yit Tay	Executive Director & CEO	3.8yrs	keine Daten	7.9% SGD 1.0m
Yung Sern Ng	Chief Commercial Officer & Executive Director	less than a year	keine Daten	1.71% SGD 220.5k
Heng Fong	Lead Independent Non-Executive Director	6.3yrs	keine Daten	keine Daten
Wing Kwan Teh	Non Independent & Non Executive Chairman	6.4yrs	keine Daten	4.65% SGD 598.5k
Jun Xiong Lim	Independent Non-Executive Director	3.8yrs	keine Daten	keine Daten
Yu Meng Chan	Independent Non-Executive Director	6.3yrs	keine Daten	keine Daten

5.0yrs

Durchschnittliche Betriebszugehörigkeit

51.5yo

Durchschnittliches Alter

Erfahrener Vorstand: PRHDie Vorstandsmitglieder gelten als erfahren (5 Jahre durchschnittliche Amtszeit).

Livingstone Health Holdings Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

High number of new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 31, 2024

Insufficient new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 27, 2023

Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller

Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations

Recent updates

Livingstone Health Holdings Limited to Report First Half, 2025 Results on Nov 14, 2024

New major risk - Market cap size

High number of new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 31, 2024

Full year 2024 earnings released: S$0.65 loss per share (vs S$0.002 profit in FY 2023)

New minor risk - Financial data availability

Livingstone Health Holdings Limited to Report Fiscal Year 2024 Results on May 30, 2024

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.574235 million.

New minor risk - Shareholder dilution

Livingstone Health Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Insufficient new directors

New major risk - Market cap size

Livingstone Health Holdings Limited to Report First Half, 2024 Results on Nov 14, 2023

New major risk - Market cap size

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.009 in FY 2022)

Livingstone Health Holdings Limited, Annual General Meeting, Jul 27, 2023

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.01 in FY 2022)

Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller

First half 2023 earnings released: EPS: S$0.002 (vs S$0.006 in 1H 2022)

Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations

Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend for the Financial Year Ended 31 March 2022, Payable on August 29, 2022

Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend, Payable on 11 August 2022

Head of Orthopaedic Surgery recently bought S$4.8m worth of stock

Livingstone Health Holdings Limited Proposes Final Dividend

Livingstone Health Holdings Limited Appoints Chua Hshan Cher as Deputy Chief Executive Officer

Livingstone Health Launches One-Stop Health Screening Centre Ardennes Healthcare Pte Ltd

Livingstone Health Holdings Limited to Report Fiscal Year 2021 Results on May 30, 2021

Livingstone Health Holdings Limited Appoints Lim Jun Xiong Steven as Independent and Non-Executive Director

Livingstone Health Ltd. completed the acquisition of Citicode Ltd. (SGX:5FH) in a reverse merger transaction.

Geschäftsführer

Amtszeit

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter